摘要
目的探讨超声引导下不同方法制作聚桂醇泡沫硬化治疗肾囊肿的临床疗效。方法以本院2014年9月~2015年8月收治的60例肾囊肿(直径>5cm)患者为研究对象,均接受超声引导下聚桂醇泡沫硬化治疗,根据患者意愿、聚桂醇泡沫硬化剂不同制作方法分为A(Monfreux法,15例)、B(Tessari法,25例)、C(Tessari/DSS法,20例)3组,术后3、6、12个月行超声复查,评价各组疗效及不良反应情况。结果 60例患者中临床治愈55例,临床治愈率91.67%,总有效率100.00%;3组患者术后3、6、12个月临床治愈率比较差异无统计学意义(P>0.05);3组不良反应发生率比较差异无统计学意义(P>0.05)。结论超声引导下聚桂醇泡沫硬化治疗直径>5cm肾囊肿患者疗效明确,不良反应少,且不同制作方法对聚桂醇泡沫硬化治疗效果影响不大。
Objective To analyze the imaging effect of ultrasound guided lauromacrogol foam sclerosing agent made by different methods in the treatment of renal cysts. Methods Sixty patients with renal cysts （diameter〉5cm） treated in our hospital between September 2014 and August 2015 were treated with ultrasound guided lauromacrogol foam sclerosing agent. According to the patients＇ will and the methods of making lauromacrogol, the subjects were divided into group A （Monfreux method）, group B （Tessari method） and group C （Tessari/DSS）. At 3 months, 6 months and 12 months after operation, ultrasonic review was performed. The imaging curative effect and adverse reactions were evaluated. Results Among the 60 cases, 55 cases were cured, the clinical cure rate was 91.67%, and the total effective rate was 100.00%. There were no significant differences in clinical cure rate between groups at 3 months, 6 months and 12 months after operation （P〉0.05）. There was no significant difference in the incidence of adverse reactions between the three groups （P〉0.05）. Conclusion The effect of ultrasound guided lauromacrogol foam sclerosing agent in the treatment of renal cysts〉5cm is definite, with few adverse reactions. Different methods of making lauromacrogol foam sclerosing agent have little effect. It is suggested that the regimen should be chosen reasonablely according to the patient＇s condition.
出处
《西部医学》
2018年第2期283-286,共4页
Medical Journal of West China
基金
云南省卫生科技计划项目(2014NS160)
关键词
肾囊肿
聚桂醇泡沫硬化剂
不同制作方法
影像学疗效
Renal cysts
Lauromacrogol foam sclerosing agent
Different fabricated methods
Imaging curative effect
